The Dose of Radioactive Iodine Needed to Ablate the Thyroid Remnant Left Behind After Thyroidectomy

NCT00115895 · clinicaltrials.gov ↗

PHASE3

Phase

UNKNOWN

Status

160

Enrollment

OTHER

Sponsor class

Conditions

Thyroid Neoplasms

Interventions

DRUG: Radioactive iodine

Sponsor

University of Helsinki

Collaborators

[object Object]